For those wanting a more in-depth understanding of how TA-65 might work, I refer to you an email conversation I had with a patient, who was concerned that a blog referenced a Blasco paper demonstrating a 50% increase in liver cancer in mice after taking TA-65.
We were both pleased to learn that his test in October of 2014 showed a median length of 9,500 base pairs (or up to 25 years improvement) and a reduction to 8.3% critically-shortened telomeres (or a 38% relative reduction):
Wanna keep the doctor away? Stick to apples. In this brief video, I discuss why statins could be more harmful than helpful:
You can keep your own score, but in my insignificant opinion, POTUS gets 4 out of 10 and a 40% grade is probably an “F”, unless we grade on a Harvard grade-inflation curve against other current POTUSes, in which case he might be worthy of a third term with an “A”.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
